A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinoma

Eur J Nucl Med. 1990;16(4-6):311-6. doi: 10.1007/BF00842786.

Abstract

Eighteen patients with suspected primary or recurrent ovarian carcinoma have been investigated in each case by the assay of serum levels of the antigen CA125, immunoscintigraphy using 131I-OC125 antibody and magnetic resonance imaging using a 0.15 Tesla system. The final diagnosis was confirmed by laparotomy or laparoscopy. Serum levels of CA125 ranged between 5 and 780 units/ml (normal range less than 35). Antibody images and MRI were truly positive in 11 patients, 2 of whom were subsequently found to have bowel tumours. MRI showed greater detail of smaller lesions whilst immunoscintigraphy was more suited to the detection of distant metastases. In 7 patients the antibody images were positive whilst the serum marker levels were normal. This pilot study provides a preliminary comparison of the more recent techniques currently being evaluated for the detection of ovarian carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal*
  • Antigens, Tumor-Associated, Carbohydrate / analysis
  • Biomarkers, Tumor / blood
  • Female
  • Humans
  • Iodine Radioisotopes
  • Magnetic Resonance Imaging*
  • Middle Aged
  • Ovarian Neoplasms / diagnosis*
  • Pilot Projects
  • Prospective Studies

Substances

  • Antibodies, Monoclonal
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • Iodine Radioisotopes